EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nose‐to‐Brain Delivery of Acyl‐Ghrelin Peptide Gold Nanoconjugates for Treatment of Neurodegenerative Diseases

Shunping Han, Rifka N Utami, Yue Qin, Revadee Liam-Or, Jemeen Sreedharan, Jeffrey S Davies, Khuloud T Al-Jamal iD

Small · 2025

DOI: 10.1002/smll.202504517 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2025. Verfasst von Shunping Han und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Science, Faculty of Life Sciences & Medicine, King's College London, Franklin-Wilkins Building, 150 Stamford Street, Lond…. Hauptthemen laut MEDLINE: Gold, Ghrelin, Nanoconjugates, Neurodegenerative Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King's College London, Indonesian Endowment Fund for Education, Brain Tumour Charity.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodegenerative diseases remain a major therapeutic challenge in aging populations. Acyl‐ghrelin, a 28‐amino acid gut hormone, demonstrates neuroprotective effects but is limited by instability, rapid clearance, and non‐specific distribution when systemically delivered. Nose‐to‐brain delivery using nanotechnology offers a promising alternative. Gold nanorods (AuNRs), with high therapeutics loading capacity, are proposed as carriers for intranasal acyl‐ghrelin delivery. The previous study demonstrates that intranasal AuNRs effectively reach the brain with minimal systemic exposure. This work investigates the feasibility of using acyl‐ghrelin gold nanoconjugates to deliver and retain its pharmacological activity through intranasal administration for neurodegenerative diseases. Acyl‐ghrelin is conjugated via its C‐terminus to hetero‐functional polyethylene glycol (PEG) using EDC/sulfo‐NHS coupling chemistry, then attached to AuNRs through stable Au─S bonds. Reaction conditions are optimized to minimize multi‐PEG substitution, preserving acyl‐ghrelin bioactivity and preventing AuNR cross‐linking. The resulting nanoconjugates successfully deliver ghrelin to the brain, reaching peak levels at 10 min post‐administration with ≈2067.6 ± 760.6 pg g −1 of brain, a fourfold increase over native expression. Importantly, the peptide retains biological function, as evidenced by AMPK phosphorylation at 30–60 min, a key marker of ghrelin‐induced neuroprotection. These findings support intranasal AuNR‐mediated delivery of acyl‐ghrelin as a promising strategy for treating neurodegenerative diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GoldGhrelinNanoconjugatesNeurodegenerative DiseasesBrainDrug Delivery SystemsAdministration, IntranasalAnimalsPolyethylene GlycolsMiceNanotubes

Stichwörter der Autor:innen

acyl‐ghrelin peptidebrain uptakegold nanorodsintranasal administrationneurodegenerative diseases

Substanzen

GoldGhrelinNanoconjugatesPolyethylene Glycols

Autor:innen und Institutionen

  • Institute of Pharmaceutical Science, Faculty of Life Sciences & Medicine, King's College London, Franklin-Wilkins Building, 150 Stamford Street, London, SE1 9NH, UK.
  • Department of Basic and Clinical Neuroscience, The Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 9RT, UK.
  • Molecular Neurobiology, Institute of Life Sciences, School of Medicine, Swansea University, Swansea, SA2 8PP, UK.

ORCID-Profile: Khuloud T Al-Jamal

Förderung

  • King's College London
  • Indonesian Endowment Fund for Education
  • Brain Tumour Charity
  • Biotechnology and Biological Sciences Research Council
  • Wellcome Trust
  • China Scholarship Council

Zitieren

APA

Han, S., Utami, R. N., Qin, Y., Liam-Or, R., Sreedharan, J., Davies, J. S., & Al-Jamal, K. T. (2025). Nose‐to‐Brain Delivery of Acyl‐Ghrelin Peptide Gold Nanoconjugates for Treatment of Neurodegenerative Diseases. Small. https://doi.org/10.1002/smll.202504517

Vancouver

Han S, Utami RN, Qin Y, Liam-Or R, Sreedharan J, Davies JS, et al. Nose‐to‐Brain Delivery of Acyl‐Ghrelin Peptide Gold Nanoconjugates for Treatment of Neurodegenerative Diseases. Small. 2025. doi:10.1002/smll.202504517

BibTeX
@article{Han2025,
  author = {Han, Shunping and Utami, Rifka N and Qin, Yue and Liam-Or, Revadee and Sreedharan, Jemeen and Davies, Jeffrey S and Al-Jamal, Khuloud T},
  title = {Nose‐to‐Brain Delivery of Acyl‐Ghrelin Peptide Gold Nanoconjugates for Treatment of Neurodegenerative Diseases},
  journal = {Small},
  year = {2025},
  doi = {10.1002/smll.202504517}
}
Kostenlos starten →